Layton Patrick Mills
Founder bei CANNPAL ANIMAL THERAPEUTICS LIMITED
Profil
Layton Patrick Mills is the founder of CannPal Animal Therapeutics Ltd., a company founded in 2016.
He holds the title of Chief Executive Officer, Director & MD at CannPal Animal Therapeutics Ltd.
Currently, Mr. Mills is a Non-Executive Director at Argent BioPharma Ltd., a position he started in 2023.
In the past, he served as the Chief Executive Officer at AusCann Group Holdings Ltd.
from 2021 to 2022.
Aktive Positionen von Layton Patrick Mills
| Unternehmen | Position | Beginn |
|---|---|---|
| CANNPAL ANIMAL THERAPEUTICS LIMITED | Founder | 03.06.2016 |
| ARGENT BIOPHARMA LIMITED | Director/Board Member | 01.06.2023 |
Ehemalige bekannte Positionen von Layton Patrick Mills
| Unternehmen | Position | Ende |
|---|---|---|
| AUSCANN GROUP HOLDINGS LTD | Chief Executive Officer | 13.09.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ARGENT BIOPHARMA LIMITED | Health Technology |
| AUSCANN GROUP HOLDINGS LTD | Process Industries |
| Private Unternehmen | 1 |
|---|---|
CannPal Animal Therapeutics Ltd.
 CannPal Animal Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology CannPal Animal Therapeutics Ltd. pharmaceutical company, which focuses on animal health. It researches, develops, and commercializes regulatory approved cannabinoid-derived therapeutic pet products for cats and dogs. The company was founded by Layton Mills on June 3, 2016 and is headquartered in Double Bay, Australia. | Health Technology |
